NYSE:HRC - Hill-Rom Stock Price, Price Target & More

$87.25 -0.19 (-0.22 %)

(As of 04/22/2018 04:00 PM ET)

Previous Close$87.25

Today's Range$86.8750 - $88.00

52-Week Range$70.73 - $91.11

Volume186,012 shs

Average Volume349,942 shs

Market Capitalization$5.77 billion

P/E Ratio22.60

Dividend Yield0.92%

Beta0.97

About Hill-Rom (NYSE:HRC)

Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It provides medical surgical beds, intensive care unit beds, bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and communications technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment. The company also offers patient monitoring and diagnostics products, such as blood pressure, physical assessment, vital signs monitoring, diagnostic cardiopulmonary, diabetic retinopathy screening, and thermometry products; and respiratory health products, including Vest, VitalCough, MetaNeb, and Monarch systems to assist patients in the mobilization of retained blockages. In addition, it provides surgical solutions products comprising surgical tables, lights, and pendants; positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries; platform-neutral positioning accessories; and operating room surgical safety and accessory products, such as scalpels and blades, light handle systems, skin markers, and other disposable products. The company sells and rents its products to acute and extended care facilities through direct sales force and distributors; and directly to patients in the home, as well as sells its products to primary care facilities through distributors. Further, it offers diagnostic cardiology devices, to serve the continuum of clinical care, from acute care to primary care, and clinical research organizations. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Chicago, Illinois.

Receive HRC News and Ratings via Email

Sign-up to receive the latest news and ratings for HRC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments

Sub-IndustryHealth Care Equipment

SectorMedical

SymbolNYSE:HRC

CUSIP43147510

Webwww.hill-rom.com

Phone312-819-7200

Debt

Debt-to-Equity Ratio1.39%

Current Ratio1.75%

Quick Ratio1.29%

Price-To-Earnings

Trailing P/E Ratio22.60

Forward P/E Ratio18.89

P/E Growth1.4

Sales & Book Value

Annual Sales$2.74 billion

Price / Sales2.10

Cash Flow$7.1341 per share

Price / Cash12.23

Book Value$20.73 per share

Price / Book4.21

Profitability

EPS (Most Recent Fiscal Year)$3.86

Net Income$133.60 million

Net Margins7.14%

Return on Equity20.24%

Return on Assets6.06%

Miscellaneous

Employees10,000

Outstanding Shares66,170,000

How to Become a New Pot Stock Millionaire

Hill-Rom (NYSE:HRC) Frequently Asked Questions

What is Hill-Rom's stock symbol?

Hill-Rom trades on the New York Stock Exchange (NYSE) under the ticker symbol "HRC."

How often does Hill-Rom pay dividends? What is the dividend yield for Hill-Rom?

Hill-Rom declared a quarterly dividend on Wednesday, March 7th. Shareholders of record on Friday, March 23rd will be paid a dividend of $0.20 per share on Friday, March 30th. This represents a $0.80 dividend on an annualized basis and a yield of 0.92%. The ex-dividend date of this dividend is Thursday, March 22nd. This is a boost from Hill-Rom's previous quarterly dividend of $0.18. View Hill-Rom's Dividend History.

How were Hill-Rom's earnings last quarter?

Hill-Rom Holdings, Inc. (NYSE:HRC) issued its earnings results on Friday, January, 26th. The medical technology company reported $0.92 EPS for the quarter, beating the Zacks' consensus estimate of $0.79 by $0.13. The medical technology company had revenue of $669.70 million for the quarter, compared to analysts' expectations of $670 million. Hill-Rom had a net margin of 7.14% and a return on equity of 20.24%. The business's quarterly revenue was up 5.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.75 EPS. View Hill-Rom's Earnings History.

When is Hill-Rom's next earnings date?

Hill-Rom is scheduled to release their next quarterly earnings announcement on Friday, April, 27th 2018. View Earnings Estimates for Hill-Rom.

What guidance has Hill-Rom issued on next quarter's earnings?

Hill-Rom updated its FY18 earnings guidance on Friday, January, 26th. The company provided earnings per share (EPS) guidance of $4.57-4.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.55. Hill-Rom also updated its Q2 guidance to $1.00-1.02 EPS.

What price target have analysts set for HRC?

9 brokerages have issued 1-year price targets for Hill-Rom's stock. Their forecasts range from $85.00 to $105.00. On average, they expect Hill-Rom's stock price to reach $93.6250 in the next year. View Analyst Ratings for Hill-Rom.

What are Wall Street analysts saying about Hill-Rom stock?

Here are some recent quotes from research analysts about Hill-Rom stock:

1. According to Zacks Investment Research, "Hill-Rom has outperformed its industry in a year's time. However, a decline in revenues at the company's Patient Support Systems segment is quite disappointing. Also, foreign exchange and a tough competitive landscape remain headwinds. On a positive note, of late the company has been seeing solid year-over-year increase in revenues on strong international growth primarily banking on the 'One Hill-Rom' approach. The company is focusing on product innovation, the latest one being Connex Cardio ECG. Hill-Rom has updated its 2020 long-range financial objectives and outlook considering gains from the new tax reform. Hill-Rom now expects to drive adjusted earnings by 12-14% on a compound annual basis through 2020, compared with the previous guidance of 10-12%. Moreover, an improvement in gross and adjusted operating margin buoys optimism." (4/12/2018)
2. Needham & Company LLC analysts commented, "Consistent with its 1/9/18 preannouncement, HRC beat consensus F1Q18 revenue and EPS. Management reiterated its FY18 revenue guidance and raised its FY18 adjusted EPS guidance due to tax reform. Organic revenue growth slowed somewhat to 2% in F1Q18 from 3% in F4Q17. Margins increased modestly Y/ Y with gross margin up 20 bps and operating margin up 10 bps and tax reform added $0.06 to EPS. One surprise was that CEO John Greisch announced his intention to retire in F3Q18; the board has initiated a CEO search. We expect new products including the Centrella bed to drive accelerating revenue growth while cost reductions and portfolio management drive margin expansion. HRC shares remain at a discount to peers (2018E P/E of 18.5x vs. small/mid-cap value peers at 24.3x) and we reiterate our Buy rating." (1/26/2018)

Who are some of Hill-Rom's key competitors?

Some companies that are related to Hill-Rom include Dexcom (DXCM), ICU Medical (ICUI), Insulet (PODD), Globus Medical (GMED), Cantel Medical (CMD), Penumbra (PEN), Haemonetics (HAE), NuVasive (NUVA), Nevro (NVRO), Merit Medical Systems (MMSI), NovoCure (NVCR), Mazor Robotics (MZOR), Irhythm Technologies (IRTC), Intersect ENT (XENT), ATRION (ATRI), Orthofix (OFIX), OraSure Technologies (OSUR) and Glaukos (GKOS).

Who are Hill-Rom's key executives?

Hill-Rom's management team includes the folowing people:

Mr. William Gerard Dempsey, Exec. Chairman (Age 67)
Mr. John J. Greisch, Pres, CEO & Director (Age 63)
Mr. Steven J. Strobel, Sr. VP & CFO (Age 60)
Ms. Deborah M. Rasin, Sr. VP, Chief Legal Officer & Sec. (Age 51)
Mr. Alton E. Shader, Sr. VP, Pres of Welch Allyn & Front Line Care (Age 45)

Has Hill-Rom been receiving favorable news coverage?

News headlines about HRC stock have trended somewhat positive on Sunday, Accern Sentiment Analysis reports. The research group identifies positive and negative news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Hill-Rom earned a media sentiment score of 0.16 on Accern's scale. They also gave media coverage about the medical technology company an impact score of 47.19 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

How do I buy shares of Hill-Rom?

Shares of HRC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Hill-Rom's stock price today?

One share of HRC stock can currently be purchased for approximately $87.25.

How big of a company is Hill-Rom?

Hill-Rom has a market capitalization of $5.77 billion and generates $2.74 billion in revenue each year. The medical technology company earns $133.60 million in net income (profit) each year or $3.86 on an earnings per share basis. Hill-Rom employs 10,000 workers across the globe.

How can I contact Hill-Rom?

Hill-Rom's mailing address is 130 East Randolph Street Suite 1000, Chicago IL, 60601. The medical technology company can be reached via phone at 312-819-7200 or via email at [email protected]

MarketBeat Community Rating for Hill-Rom (HRC)

Community Ranking:		2.5 out of 5 ( )
Outperform Votes:		245 (Vote Outperform)
Underperform Votes:		238 (Vote Underperform)
Total Votes:		483

MarketBeat's community ratings are surveys of what our community members think about Hill-Rom and other stocks. Vote "Outperform" if you believe HRC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HRC will underperform the S&P 500 over the long term. You may vote once every thirty days.

Hill-Rom (NYSE:HRC) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

9 Wall Street analysts have issued ratings and price targets for Hill-Rom in the last 12 months. Their average twelve-month price target is $93.6250, suggesting that the stock has a possible upside of 7.31%. The high price target for HRC is $105.00 and the low price target for HRC is $85.00. There are currently 4 hold ratings and 5 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.56	2.63	2.63	2.83
Ratings Breakdown:	0 Sell Rating(s) 4 Hold Rating(s) 5 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 3 Hold Rating(s) 5 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 3 Hold Rating(s) 5 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 5 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$93.6250	$94.8571	$94.8571	$86.8333
Price Target Upside:	7.31% upside	7.83% upside	7.66% upside	11.37% upside

Hill-Rom (NYSE:HRC) Consensus Price Target History

Price Target History for Hill-Rom (NYSE:HRC)

Hill-Rom (NYSE:HRC) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/4/2018	Goldman Sachs	Initiated Coverage	Neutral -> Neutral	$85.00	Low
1/26/2018	Needham & Company LLC	Reiterated Rating	Buy		Low
1/18/2018	KeyCorp	Reiterated Rating	Buy	$97.00	Low
1/10/2018	Barclays	Reiterated Rating	Buy	$100.00	Low
1/3/2018	Raymond James	Upgrade	Market Perform -> Outperform	$94.00	High
1/2/2018	Morgan Stanley	Downgrade	Overweight -> Equal Weight		Low
11/29/2017	Stifel Nicolaus	Reiterated Rating	Buy	$92.00	Low
11/22/2017	Bank of America	Reiterated Rating	Hold		N/A
7/28/2017	Cantor Fitzgerald	Set Price Target	Hold	$86.00	Low

(Data available from 4/22/2016 forward)

Hill-Rom (NYSE:HRC) Earnings History and Estimates Chart

Earnings by Quarter for Hill-Rom (NYSE:HRC)

Hill-Rom (NYSE:HRC) Earnings Estimates

2018 EPS Consensus Estimate: $4.48
2019 EPS Consensus Estimate: $5.06

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	2	$0.78	$0.79	$0.79
Q2 2018	2	$1.02	$1.02	$1.02
Q3 2018	2	$1.17	$1.18	$1.18
Q4 2018	2	$1.50	$1.50	$1.50
Q1 2019	1	$0.99	$0.99	$0.99
Q2 2019	1	$1.15	$1.15	$1.15
Q3 2019	1	$1.29	$1.29	$1.29
Q4 2019	1	$1.63	$1.63	$1.63
Q1 2020	1	$1.11	$1.11	$1.11
Q2 2020	1	$1.29	$1.29	$1.29

Hill-Rom (NYSE HRC) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
4/26/2018		$1.02					N/A
1/26/2018	Q1 2018	$0.79	$0.92	$670.00 million	$669.70 million	View	Listen
11/3/2017	Q4 2017	$1.27	$1.32	$731.10 million	$738.30 million	View	N/A
7/28/2017	Q3 2017	$0.90	$0.91	$695.50 million	$689.10 million	View	N/A
4/28/2017	Q2 2017	$0.7880	$0.88	$654.27 million	$678.90 million	View	N/A
1/27/2017	Q117	$0.75	$0.75	$654.12 million	$637.40 million	View	Listen
11/3/2016	Q416	$1.13	$1.18	$701.39 million	$706.00 million	View	Listen
8/4/2016	Q316	$0.76	$0.81	$647.75 million	$655.40 million	View	Listen
4/29/2016	Q216	$0.70	$0.71	$650.99 million	$633.00 million	View	Listen
2/1/2016	Q116	$0.65	$0.68	$659.50 billion	$661.20 billion	View	N/A
11/5/2015	Q415	$0.76	$0.83	$541.47 million	$574.00 million	View	N/A
8/7/2015	Q315	$0.61	$0.62	$447.54 million	$475.00 million	View	N/A
5/5/2015	Q215	$0.60	$0.64	$472.10 million	$475.00 million	View	N/A
2/3/2015	Q115	$0.50	$0.49	$453.59 million	$465.00 million	View	N/A
11/5/2014	Q414	$0.71	$0.74	$467.50 million	$479.00 million	View	Listen
8/7/2014	Q314	$0.59	$0.59	$411.41 million	$398.00 million	View	Listen
5/2/2014	Q214	$0.51	$0.57	$412.02 million	$415.00 million	View	N/A
1/22/2014	Q114	$0.51	$0.36	$406.04 million	$393.40 million	View	N/A
10/23/2013	Q413	$0.60	$0.65	$437.90 million	$438.00 million	View	N/A
7/24/2013	Q3 2013	$0.50	$0.49	$426.56 million	$424.00 million	View	N/A
4/24/2013	Q2 2013	$0.50	$0.49	$438.06 million	$425.70 million	View	N/A
1/23/2013	Q1 2013	$0.44	$0.47	$414.20 million	$428.00 million	View	N/A
10/24/2012		$0.56	$0.56			View	N/A
7/25/2012		$0.57	$0.56			View	N/A
4/25/2012		$0.54	$0.59			View	N/A
1/25/2012		$0.53	$0.53			View	N/A
10/26/2011		$0.70	$0.72			View	N/A
7/27/2011		$0.55	$0.47			View	N/A
4/27/2011		$0.50	$0.54			View	N/A
1/26/2011		$0.45	$0.55			View	N/A
10/27/2010	Q4 2010	$0.55	$0.67			View	N/A
7/28/2010	Q3 2010	$0.31	$0.45			View	N/A
5/4/2010	Q2 2010	$0.30	$0.33			View	N/A
2/3/2010	Q1 2010	$0.26	$0.31			View	N/A
11/11/2009	Q4 2009	$0.30	$0.41			View	N/A
8/6/2009	Q3 2009	$0.20	$0.25			View	N/A
5/4/2009	Q2 2009	$0.15	$0.27			View	N/A
2/4/2009	Q1 2009		$0.25			View	N/A
11/10/2008	Q4 2008	$0.54	$0.58			View	N/A
8/6/2008	Q3 2008	$0.23	$0.22			View	N/A
5/13/2008	Q2 2008		$0.15			View	N/A
2/6/2008	Q1 2008		$0.74			View	N/A

(Earnings results data provided by Zacks Investment Research)

Hill-Rom (NYSE:HRC) Dividend Information

Hill-Rom pays an annual dividend of $0.80 per share, with a dividend yield of 0.92%. HRC's most recent quarterly dividend payment was Friday, March 30. The company has grown its dividend for the last 7 consecutive years and is increasing its dividend by an average of 5.70% each year. Hill-Rom pays out 20.73% of its earnings out as a dividend.

Most Recent Dividend:	3/30/2018
Annual Dividend:	$0.80
Dividend Yield:	0.92%
Dividend Growth:	5.70% (3 Year Average)
Payout Ratio:	20.73% (Trailing 12 Months of Earnings) 17.32% (Based on This Year's Estimates) 15.63% (Based on Next Year's Estimates)
Track Record:	7 Years of Consecutive Dividend Growth
Frequency:	Quarterly Dividend

Dividend Payments by Quarter for Hill-Rom (NYSE:HRC)

Hill-Rom (NYSE:HRC) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/7/2018	Quarterly	$0.20		3/22/2018	3/23/2018	3/30/2018
11/8/2017	Quarterly	$0.18	0.92%	12/14/2017	12/15/2017	12/29/2017
7/19/2017	Quarterly	$0.18	0.86%	9/14/2017	9/15/2017	9/29/2017
5/26/2017	Quarterly	$0.18	0.94%	6/14/2017	6/16/2017	6/30/2017
3/15/2017	quarterly	$0.18	1.03%	3/22/2017	3/24/2017	3/31/2017
11/17/2016	Quarterly	$0.17		12/14/2016	12/16/2016	12/30/2016
7/20/2016	Quarterly	$0.17		9/14/2016	9/16/2016	9/30/2016
5/6/2016	Quarterly	$0.17		6/8/2016	6/10/2016	6/24/2016
2/26/2016	Quarterly	$0.17		3/10/2016	3/14/2016	3/28/2016
11/17/2015	Quarterly	$0.16		12/11/2015	12/15/2015	12/31/2015
7/22/2015		$0.16		9/14/2015	9/16/2015	9/30/2015
5/1/2015	quarterly	$0.16	1.28%	6/11/2015	6/15/2015	6/30/2015
3/5/2015	quarterly	$0.16	1.32%	3/13/2015	3/17/2015	3/31/2015
12/3/2014	quarterly	$0.1525	1.33%	12/11/2014	12/15/2014	12/29/2014
9/3/2014	quarterly	$0.1525	1.41%	9/12/2014	9/16/2014	9/30/2014
5/7/2014	quarterly	$0.1525	1.59%	6/11/2014	6/13/2014	6/27/2014
3/7/2014	quarterly	$0.1525	1.59%	3/18/2014	3/20/2014	3/31/2014
11/20/2013	quarterly	$0.1375	1.3%	12/11/2013	12/13/2013	12/27/2013
9/10/2013	quarterly	$0.1375	1.55%	9/18/2013	9/20/2013	9/30/2013
5/29/2013	quarterly	$0.1375	1.52%	6/12/2013	6/14/2013	6/28/2013
3/4/2013	quarterly	$0.1250	1.49%	3/13/2013	3/15/2013	3/29/2013

(Data available from 1/1/2013 forward)

Hill-Rom (NYSE HRC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.90%
Institutional Ownership Percentage: 82.49%

Insider Trading History for Hill-Rom (NYSE:HRC)

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Hill-Rom (NYSE HRC) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/12/2018	Deborah Rasin	SVP	Sell	7,590	$86.02	$652,891.80	14,028
12/15/2017	John J Greisch	CEO	Sell	125,241	$82.59	$10,343,654.19	280,851
12/13/2017	Paul Sherwood Johnson	SVP	Sell	1,000	$82.99	$82,990.00	1,066
12/12/2017	John J Greisch	CEO	Sell	100,000	$82.82	$8,282,000.00	230,851
12/5/2017	Mary Garrett	Director	Buy	300	$83.30	$24,990.00	300
9/14/2017	Andreas G Frank	SVP	Sell	6,870	$77.48	$532,287.60	16,701
9/13/2017	Andreas G Frank	SVP	Sell	3,940	$77.84	$306,689.60	16,701
6/6/2017	Andreas G Frank	SVP	Sell	10,660	$78.62	$838,089.20	28,988
5/17/2017	Paul Sherwood Johnson	SVP	Sell	2,078	$72.30	$150,239.40
3/16/2017	Alton Shader	SVP	Sell	15,000	$69.34	$1,040,100.00	52,638
3/7/2017	John J Greisch	CEO	Sell	207,987	$65.86	$13,698,023.82	301,565
2/9/2017	Paul Sherwood Johnson	SVP	Sell	1,403	$60.95	$85,512.85	2,078
1/13/2017	Andrew Macritchie	Insider	Buy	58,000	$0.03	$1,740.00
11/17/2016	Carlyn D Solomon	COO	Sell	40,515	$54.78	$2,219,411.70	22,163
2/22/2016	Stephen Martin Leahy	Director	Buy	6,000	$0.04	$240.00
2/19/2016	Stephen Martin Leahy	Director	Buy	1,000	$0.04	$40.00
2/18/2016	Stephen Martin Leahy	Director	Buy	31,000	$0.04	$1,240.00
2/17/2016	Stephen Martin Leahy	Director	Buy	129,000	$0.04	$5,160.00
2/16/2016	Stephen Martin Leahy	Director	Buy	92,000	$0.04	$3,680.00
2/10/2016	Stephen Martin Leahy	Director	Buy	172,000	$0.04	$6,880.00
1/29/2016	Stephen Martin Leahy	Director	Sell	431,000	$0.02	$8,620.00
9/4/2015	Richard David Williams	Director	Buy	5,000	$0.02	$100.00
9/3/2015	Richard David Williams	Director	Buy	10,000	$0.02	$200.00
8/31/2015	Richard David Williams	Director	Buy	7,000	$0.02	$140.00
11/25/2014	Andreas G Frank	SVP	Sell	20,554	$45.89	$943,223.06
8/19/2014	Richard G Keller	CAO	Sell	14,736	$43.18	$636,300.48
2/4/2013	W August Hillenbrand	Director	Sell	3,195	$32.99	$105,403.05
8/10/2012	Edward Gregory Pritchard	SVP	Buy	7,500	$26.74	$200,550.00

(Data available from 1/1/2013 forward)

Hill-Rom (NYSE HRC) News Headlines

Source:

Date	Headline
	Hill-Rom Enhances Spot™ Vision Screener To Serve Senior Population finance.yahoo.com - April 20 at 8:04 AM
	Zacks Investment Research Downgrades Hill-Rom (HRC) to Hold www.americanbankingnews.com - April 19 at 11:31 AM
	Hill-Rom (HRC) Set to Announce Quarterly Earnings on Thursday www.americanbankingnews.com - April 19 at 1:38 AM
	Hill-Rom (HRC) Stock Rating Lowered by BidaskClub www.americanbankingnews.com - April 16 at 8:07 PM
	Insider Selling: Hill-Rom Holdings, Inc. (HRC) SVP Sells 7,590 Shares of Stock www.americanbankingnews.com - April 16 at 7:14 PM
	Hill-Rom (HRC) Downgraded to "Hold" at BidaskClub www.americanbankingnews.com - April 14 at 10:53 PM
	Zacks Investment Research Lowers Hill-Rom (HRC) to Sell www.americanbankingnews.com - April 14 at 10:43 AM
	Hill-Rom (HRC) Lowered to "Sell" at Zacks Investment Research www.americanbankingnews.com - April 12 at 12:33 PM
	Equities Analysts Set Expectations for Hill-Rom Holdings, Inc.'s FY2018 Earnings (HRC) www.americanbankingnews.com - April 12 at 7:40 AM
	Zacks: Brokerages Expect Hill-Rom Holdings, Inc. (HRC) Will Announce Quarterly Sales of $709.03 Million www.americanbankingnews.com - April 12 at 4:37 AM
	Hill-Rom Holdings, Inc. to Post Q4 2018 Earnings of $1.50 Per Share, Northcoast Research Forecasts (HRC) www.americanbankingnews.com - April 11 at 9:01 AM
	Add These 7 GARP Stocks to Enhance Your Portfolio Returns finance.yahoo.com - April 11 at 8:02 AM
	Zacks: Brokerages Expect Hill-Rom Holdings, Inc. (HRC) to Announce $1.02 EPS www.americanbankingnews.com - April 10 at 5:25 AM
	Hill-Rom (HRC) Receives "Buy" Rating from KeyCorp www.americanbankingnews.com - April 6 at 9:16 PM
	Hill-Rom (HRC) Downgraded by Zacks Investment Research to Hold www.americanbankingnews.com - April 6 at 12:35 PM
	Hill-Rom (HRC) Stock Rating Upgraded by Zacks Investment Research www.americanbankingnews.com - April 5 at 2:14 PM
	Goldman Sachs Begins Coverage on Hill-Rom (HRC) www.americanbankingnews.com - April 4 at 8:04 AM
	Where Hill-Rom Holdings Inc (NYSE:HRC) Stands In Terms Of Earnings Growth Against Its Industry finance.yahoo.com - April 3 at 8:03 AM
	Hill-Rom Holdings, Inc. (HRC) Given Average Rating of "Buy" by Brokerages www.americanbankingnews.com - April 1 at 8:03 AM
	Hill-Rom (HRC) Cut to Equal Weight at Morgan Stanley www.americanbankingnews.com - March 31 at 12:49 PM
	Hill-Rom (HRC) Rating Reiterated by KeyCorp www.americanbankingnews.com - March 27 at 1:17 PM
	Hill-Rom Showcases Surgical Leadership and New Safety Innovations at AORN 2018 finance.yahoo.com - March 26 at 8:02 AM
	Hill-Rom Holdings, Inc. (HRC) Expected to Announce Quarterly Sales of $709.03 Million www.americanbankingnews.com - March 26 at 6:53 AM
	$1.02 EPS Expected for Hill-Rom Holdings, Inc. (HRC) This Quarter www.americanbankingnews.com - March 24 at 5:28 AM
	Calculating The Fair Value Of Hill-Rom Holdings Inc (NYSE:HRC) finance.yahoo.com - March 18 at 6:34 PM
	Hill-Rom To Host Fiscal Second Quarter 2018 Earnings Conference Call And Webcast finance.yahoo.com - March 15 at 6:32 PM
	HRC WORLD PLC: LAUNCHING OF HRC MUSIC finance.yahoo.com - March 15 at 9:06 AM
	Hill-Rom Holdings (HRC) to Divest Third-Party Rental Business www.streetinsider.com - March 14 at 8:04 AM
	Hill-Rom Announces Divestiture Of Third-Party Rental Business finance.yahoo.com - March 12 at 7:14 AM
	Zacks: Analysts Expect Hill-Rom Holdings, Inc. (HRC) Will Post Quarterly Sales of $709.03 Million www.americanbankingnews.com - March 9 at 3:23 PM
	Hill-Rom Holdings, Inc. (HRC) Plans Dividend Increase - $0.20 Per Share www.americanbankingnews.com - March 8 at 9:59 AM
	Hill-Rom Holdings, Inc. (HRC) Receives Consensus Rating of "Buy" from Brokerages www.americanbankingnews.com - March 7 at 11:45 AM
	Hill-Rom Raises Quarterly Dividend finance.yahoo.com - March 7 at 8:06 AM
	Hill-Rom Debuts Enhanced Workflow Efficiency And Security Features For Welch Allyn Connex® Vitals Monitoring Devices finance.yahoo.com - March 6 at 5:48 PM
	Sectoral Asset Management Inc Takes $5.85 Million Position in Hill-Rom Holdings, Inc. (HRC) www.americanbankingnews.com - March 5 at 3:34 PM
	Hill-Rom Holdings, Inc. (HRC) Shares Sold by Koch Industries Inc. www.americanbankingnews.com - March 5 at 2:26 PM
	State of Tennessee Treasury Department Grows Holdings in Hill-Rom Holdings, Inc. (HRC) www.americanbankingnews.com - March 5 at 9:45 AM
	Hill-Rom Holdings, Inc. to Post FY2018 Earnings of $4.64 Per Share, Northcoast Research Forecasts (HRC) www.americanbankingnews.com - March 5 at 5:38 AM
	Hill-Rom Holdings, Inc. (HRC) Shares Sold by Schroder Investment Management Group www.americanbankingnews.com - March 4 at 11:05 AM
	Hill-Rom Holdings, Inc. (HRC) Shares Bought by The Manufacturers Life Insurance Company www.americanbankingnews.com - March 4 at 9:32 AM
	Kennedy Capital Management Inc. Lowers Holdings in Hill-Rom Holdings, Inc. (HRC) www.americanbankingnews.com - March 4 at 8:24 AM
	ValuEngine Upgrades Hill-Rom (HRC) to Buy www.americanbankingnews.com - March 3 at 5:22 PM
	Hill-Rom Holdings, Inc. (HRC) Holdings Reduced by Globeflex Capital L P www.americanbankingnews.com - March 2 at 3:48 PM
	BlackRock Inc. Boosts Position in Hill-Rom Holdings, Inc. (HRC) www.americanbankingnews.com - March 2 at 4:56 AM
	Allianz Asset Management GmbH Grows Holdings in Hill-Rom Holdings, Inc. (HRC) www.americanbankingnews.com - March 1 at 4:10 AM
	Hill-Rom Holdings, Inc. (HRC) Shares Bought by Liberty Mutual Group Asset Management Inc. www.americanbankingnews.com - February 28 at 12:56 PM
	Rhumbline Advisers Has $12.28 Million Holdings in Hill-Rom Holdings, Inc. (HRC) www.americanbankingnews.com - February 28 at 7:52 AM
	Arizona State Retirement System Has $3.99 Million Stake in Hill-Rom Holdings, Inc. (HRC) www.americanbankingnews.com - February 28 at 5:02 AM
	Hill-Rom Holdings, Inc. (HRC) Stake Decreased by Bank of New York Mellon Corp www.americanbankingnews.com - February 28 at 4:58 AM
	Hill-Rom Holdings, Inc. (HRC) Holdings Cut by Systematic Financial Management LP www.americanbankingnews.com - February 27 at 11:28 AM

Hill-Rom (NYSE:HRC) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Hill-Rom (NYSE:HRC) Income Statement, Balance Sheet and Cash Flow Statement

Hill-Rom (NYSE HRC) Stock Chart for Sunday, April, 22, 2018

Loading chart…

This page was last updated on 4/22/2018 by MarketBeat.com Staff